Esther Welkowsky
Direttore Tecnico/Scientifico/R&S presso ELICIO THERAPEUTICS, INC.
Profilo
Esther Welkowsky is currently the Vice President-Clinical Development at Elicio Therapeutics, Inc. (United States) and the Senior Vice President-Clinical Development at Elicio Therapeutics, Inc. She previously worked as the Executive Director-Clinical Operations at Allogene Therapeutics, Inc. from 2018 to 2020.
Prior to that, she was the Head-Clinical Operations at Atara Biotherapeutics, Inc. Ms. Welkowsky completed her undergraduate degree at the University of California, Santa Barbara.
Posizioni attive di Esther Welkowsky
| Società | Posizione | Inizio |
|---|---|---|
| ELICIO THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Elicio Therapeutics, Inc. (Old)
 Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/04/2020 |
Precedenti posizioni note di Esther Welkowsky
| Società | Posizione | Fine |
|---|---|---|
| ALLOGENE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2020 |
| ATARA BIOTHERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Esther Welkowsky
| University of California, Santa Barbara | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ALLOGENE THERAPEUTICS, INC. | Health Technology |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| ELICIO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Elicio Therapeutics, Inc. (Old)
Elicio Therapeutics, Inc. (Old) BiotechnologyHealth Technology Elicio Therapeutics, Inc. engages in the development of vaccines for infectious disease and cancer. Its programs focus on a novel lipid nanocapsule platform technology for delivering vaccines in a form mimicking the structure of pathogens to elicit potent immunity in prophylactic and therapeutic settings. The company was founded by Satish Jindal and Darrell Irvine on August 10, 2011 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Esther Welkowsky
